Direct Oral Anticoagulant (DOAC) Dosing for Stroke Prevention in those with Non-Valvular Atrial Fibrillation

WooCommerce is required for FooEvents. Please install and activate the latest version of WooCommerce.

Direct Oral Anticoagulant (DOAC) Dosing for Stroke Prevention in those with Non-Valvular Atrial Fibrillation - GPnotebook Education

This site is intended for healthcare professionals

This GPnotebook Shortcut provides an up-to-date (as of January 2019) guidance on the appropriate dosing of the Direct-Acting Oral Anticoagulants (DOACs) for stroke prevention in those with non-valvular atrial fibrillation in the UK.

The information provided herein should not be used for diagnosis or treatment of any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Any distribution or duplication of the information contained herein is strictly prohibited. GPnotebook Education stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook Education.